Skip to main content

Cholesterol—A Janus-Faced Molecule in the Central Nervous System

  • Reference work entry
  • First Online:

Abstract:

Understanding the role of cholesterol in normal brain function and its involvement in specific neurodegenerative diseases has attracted considerable attention. One general observation is that there are notable differences in the brain cholesterol properties and dynamics as compared with cholesterol outside of the brain. In addition, much of what is known of brain cholesterol is based on studies focusing on the total or bulk amount of cholesterol; however, it is becoming increasingly recognized that cholesterol domains may provide greater insight into the cellular function of cholesterol. This chapter, therefore, examines the role of cholesterol in brain, compares the properties and dynamics of brain and peripheral cholesterol, and describes cholesterol domains and the contribution of cholesterol to brain pathophysiology, with an emphasis on Alzheimer's disease (AD). Attention is also directed at the participation of other compounds in the brain cholesterol biosynthetic pathway, namely isoprenoids and the cholesterol metabolites, oxysterols.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   249.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

AD:

Alzheimer's disease

APP:

amyloid precursor protein

Aβ:

amyloid β-protein

BBB:

blood–brain barrier

CSF:

cerebrospinal fluid

CYP46A1:

cholesterol 24-hydroxylase

DHCR7:

3β-hydroxysterol Δ7-reductase

FPP:

farnesyl pyrophosphate

GGPP:

geranylgeranyl pyrophosphate

GPI:

Glycosylphosphatidylinositol

HD:

Huntington's disease

NPC:

Niemann–Pick type C

P-gp:

P-glycoprotein

LDL:

low-density lipoproteins

LRP:

low-density lipoprotein receptor-related protein

SLOS:

Smith–Lemli–Opitz syndrome

References

  • Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, et al. 2004. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 167: 953–960.

    CAS  PubMed  Google Scholar 

  • Agranoff BW. 1989. Lipids. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Siegel G, Agranoff B, Albers RW, Molinoff P, editors. New York: Raven Press, Ltd. pp. 91–107.

    Google Scholar 

  • Anderson RGW. 1993. Caveolae: Where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 90: 10909–10913.

    CAS  PubMed  Google Scholar 

  • Anderson RGW, Jacobson K. 2002. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296: 1821–1825.

    CAS  PubMed  Google Scholar 

  • Andersson M, Appelkvist EL, Kristensson K, Dallner G. 1987. Distribution of dolichol and dolichyl phosphate in human brain. J Neurochem 49: 685–691.

    CAS  PubMed  Google Scholar 

  • Arismendi-Morillo G, Castellano A. 2005. Tumoral micro-blood vessels and vascular microenvironment in human astrocytic tumors. A transmission electron microscopy study. J Neuro-Oncol 73: 211–217.

    CAS  Google Scholar 

  • Beffert U, Aumont N, Dea D, Lussier-Cacan S, Davignon J, et al. 1998. β-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons. J Neurochem 70: 1458–1466.

    CAS  PubMed  Google Scholar 

  • Björkhem I, Diczfalusy U. 2002. Oxysterols. Arterioscler Thromb Vasc Biol 22: 734–742.

    PubMed  Google Scholar 

  • Blanchette-Mackie EJ, Dwyer NK, Amende LM, Kruth HS, Butler JD, et al. 1988. Type-C Niemann–Pick disease: Low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. Proc Natl Acad Sci USA 85: 8022–8026.

    CAS  PubMed  Google Scholar 

  • Bodovitz S, Klein WL. 1996. Cholesterol modulates α-secretase cleavage of amyloid precursor protein. J Biol Chem 271: 4436–4440.

    CAS  PubMed  Google Scholar 

  • Bogman K, Peyer A-K, Török M, Küsters E, Drewe J. 2001. HMG-CoA reductase inhibitors and P-glycoprotein modulation. Br J Pharmacol 132: 1183–1192.

    CAS  PubMed  Google Scholar 

  • Bouillot C, Prochiantz A, Rougon G, Allinquant B. 1996. Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties. J Biol Chem 271: 7640–7644.

    CAS  PubMed  Google Scholar 

  • Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. 1985. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76: 1501–1513.

    CAS  PubMed  Google Scholar 

  • Brown DA, London E. 1998. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14: 111–136.

    CAS  PubMed  Google Scholar 

  • Brown DA, London E. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275: 17221–17224.

    CAS  PubMed  Google Scholar 

  • Bu J, Bruckner SR, Sengoku T, Geddes JW, Estus S. 2003. Glutamate regulates caveolin expression in rat hippocampal neurons. J Neurosci Res 72: 185–190.

    CAS  PubMed  Google Scholar 

  • Burns M, Duff K. 2002. Cholesterol in Alzheimer's disease and tauopathy. Ann NY Acad Sci 977: 367–375.

    CAS  PubMed  Google Scholar 

  • Burns MP, Igbavboa U, Wood WG, Duff K. 2004. Common effects of statins on CNS cholesterol and APP processing. Abstract Viewer/Itinerary Planner, Society for Neuroscience 716.4.

    Google Scholar 

  • Buttini M, Yu GQ, Shockley K, Huang Y, Jones B, et al. 2002. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid β peptides but not on plaque formation. J Neurosci 22: 10539–10548.

    CAS  PubMed  Google Scholar 

  • Cameron PL, Ruffin JW, Bollag R, Rasmussen H, Cameron RS. 1997. Identification of caveolin and caveolin-related proteins in the brain. J Neurosci 17: 9520–9535.

    CAS  PubMed  Google Scholar 

  • CDC/NCHS 2003. Cholesterol status among adults in the United States. National Health and Nutrition Examination Survey, CDC/NCHS.

    Google Scholar 

  • Chamberlain LH, Burgoyne RD, Gould GW. 2001. SNARE proteins are highly enriched in lipid rafts in PC12 cells: Implications for the spatial control of exocytosis. Proc Natl Acad Sci USA 98: 5619–5624.

    CAS  PubMed  Google Scholar 

  • Chung YM, Bae YS, Lee SY. 2003. Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis. Free Radic Biol Med 34: 434–442.

    CAS  PubMed  Google Scholar 

  • Connor J, Schroit AJ. 1990. Aminophospholipid translocation in erythrocytes: Evidence for the involvement of a specific transporter and an endofacial protein. Biochemistry 29: 37–43.

    CAS  PubMed  Google Scholar 

  • Cordle A, Landreth G. 2005. 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate β-amyloid-induced microglial inflammatory responses. J Neurosci 25: 299–307.

    CAS  PubMed  Google Scholar 

  • Crisby M, Rahman SMA, Sylvén C, Winblad B, Schultzberg M. 2004. Effects of high-cholesterol diet on gliosis in apolipoprotein E knockout mice Implications for Alzheimer's disease and stroke. Neurosci Lett 369: 87–92.

    CAS  PubMed  Google Scholar 

  • Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, et al. 2004. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci USA 101: 2070–2075.

    CAS  PubMed  Google Scholar 

  • Dam H. 1958. Historical introduction to cholesterol. Chemistry, Biochemistry and Pathology. Cook RP, editor. New York: Academic Press; pp. 1–14.

    Google Scholar 

  • Dekroon RM, Armati PJ. 2003. The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes. Neurobiol Dis 8: 78–89.

    Google Scholar 

  • Diaz C, Schroit AJ. 1996. Role of translocases in the generation of phosphatidylserine asymmetry. J Membr Biol 151: 1–9.

    CAS  PubMed  Google Scholar 

  • Dietschy JM. 1997. Overview of cholesterol and lipoprotein metabolism in the brain, liver and extrahepatic organs. Nutr Metab Cardiovasc Dis 7: 162–168.

    CAS  Google Scholar 

  • Dietschy JM, Turley SD. 2004. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45: 1375–1397.

    CAS  PubMed  Google Scholar 

  • Dougherty RM, Galli C, Ferro-Luzzi A, Iacono JM. 1987. Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: A study of normal subjects from, Italy, Finland, and the USA. Am J Clin Nuer 45: 443–455.

    CAS  Google Scholar 

  • Eckert GP, Igbavboa U, Müller WE, Wood WG. 2003. Lipid rafts of purified mouse brain synaptosomes prepared with or without detergent reveal different lipid and protein domains. Brain Res 962: 144–150.

    CAS  PubMed  Google Scholar 

  • Eckert GP, Kirsch C, Müller WE. 2001. Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice. Neuroreport 12: 883–887.

    CAS  PubMed  Google Scholar 

  • Edidin M. 2003. The state of lipid rafts: From model membranes to cells. Annu Rev Biophys Biomol Struct 32: 257–283.

    CAS  PubMed  Google Scholar 

  • Fagan AM, Holtzman DM. 2000. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-β deposition in vivo. Microsc Res Tech 50: 297–304.

    CAS  PubMed  Google Scholar 

  • Fagan AM, Holtzman DM, Munson G, Mathur T, Schneider D, et al. 1999. Unique lipoproteins secreted by primary astrocytes from wild type, apoE(−/−), and human apoE transgenic mice. J Biol Chem 274: 30001–30007.

    CAS  PubMed  Google Scholar 

  • Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, et al. 2001. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ 42 and Aβ 40 in vitro and in vivo. Proc Natl Acad Sci USA 98: 5856–5861.

    CAS  PubMed  Google Scholar 

  • Fielding CJ, Fielding PE. 2003. Relationship between cholesterol trafficking and signaling in rafts and caveolae. Biochim Biophys Acta 1610: 219–228.

    CAS  PubMed  Google Scholar 

  • Garrigues A, Escargueil AE, Orlowski S. 2002. The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane. Proc Natl Acad Sci USA 99: 10347–10352.

    CAS  PubMed  Google Scholar 

  • Gaudreault SB, Chabot C, Gratton J-P, Poirier J. 2004. The caveolin scaffolding domain modifies 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor binding properties by inhibiting phospholipase A2 activity. J Biol Chem 279: 356–362.

    CAS  PubMed  Google Scholar 

  • Gong JS, Kobayashi M, Hayashi H, Zou K, Sawamura N, et al. 2002. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human apoE3 and apoE4 knockin mice. J Biol Chem 277: 29919–29926.

    CAS  PubMed  Google Scholar 

  • Harr SD, Uint L, Hollister R, Hyman BT, Mendez AJ. 1996. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem 66: 2429–2435.

    CAS  PubMed  Google Scholar 

  • Hayashi H, Campenot RB, Vance DE, Vance JE. 2004. Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J Biol Chem 279: 14009–14015.

    CAS  PubMed  Google Scholar 

  • Hayashi H, Igbavboa U, Hamanaka H, Kobayashi M, Fujita SC, et al. 2002. Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knockin mice. Neuroreport 13: 383–386.

    CAS  PubMed  Google Scholar 

  • Hayashi H, Mizuno T, Michikawa M, Haass C, Yanagisawa K. 2000. Amyloid precursor protein in unique cholesterol-rich microdomains different from caveolae-like domains. Biochim Biophys Acta 1483: 81–90.

    CAS  PubMed  Google Scholar 

  • Heart Protection Study Collaborative Group 2002. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360: 7-22.

    Google Scholar 

  • Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. 2003. Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol 60: 1119–1122.

    PubMed  Google Scholar 

  • Hering H, Lin CC, Sheng M. 2003. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 23: 3262–3271.

    CAS  PubMed  Google Scholar 

  • Heverin M, Meaney S, Lütjohann D, Diczfalusy U, Wahren J, et al. 2005. Crossing the barrier: Net flux of 27-hydroxycholesterol into the human brain. J Lipid Res 46: 1047–1052.

    CAS  PubMed  Google Scholar 

  • Holstein SA, Hohl RJ. 2004. Isoprenoids: Remarkable diversity of form and function. Lipids 39: 293–309.

    CAS  PubMed  Google Scholar 

  • Holtzman DM. 2004. In vivo effects of ApoE and clusterin on amyloid-β metabolism and neuropathology. J Mol Neurosci 23: 247–254.

    CAS  PubMed  Google Scholar 

  • Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, et al. 1995. Low-density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci USA 92: 9480–9484.

    CAS  PubMed  Google Scholar 

  • Hooper NM. 1999. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts, and caveolae (Review). Mol Mem Biol 16: 145–156.

    CAS  Google Scholar 

  • Howlands DS, Trusko SP, Savage MJ, Reaume AG, Lang DM, et al. 1998. Modulation of secreted β-amyloid precursor protein and amyloid β peptide in brain by cholesterol. J Biol Chem 273: 16576–16582.

    Google Scholar 

  • Huang Y, Weisgraber KH, Mucke L, Mahley RW. 2004. Apolipoprotein E: Diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci 23: 189–204.

    CAS  PubMed  Google Scholar 

  • Igbavboa U, Avdulov NA, Chochina SV, Wood WG. 1997. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins. J Neurochem 69: 1661–1667.

    CAS  PubMed  Google Scholar 

  • Igbavboa U, Avdulov NA, Schroeder F, Wood WG. 1996. Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice. J Neurochem 66: 1717–1725.

    CAS  PubMed  Google Scholar 

  • Igbavboa U, Eckert GP, Malo TM, Studniski A, Johnson LNA, et al. 2005. Murine synaptosomal lipid raft protein and lipid composition are altered by expression of human apoE3 and 4 and by increasing age. J Neurol Sci 229–230: 225–232.

    PubMed  Google Scholar 

  • Igbavboa U, Hamilton J, Kim H-Y, Sun GY, Wood WG. 2002. A new role for apolipoprotein E: Modulating transport of polyunsaturated phospholipid molecular species in synaptic plasma membranes. J Neurochem 80: 255–261.

    CAS  PubMed  Google Scholar 

  • Igbavboa U, Pidcock JM, Johnson LNA, Malo TM, Studniski A, et al. 2003. Cholesterol distribution in the Golgi complex of DITNC1 astrocytes is differentially altered by fresh and aged amyloid β-peptide1–42. J Biol Chem 278: 17150–17157.

    CAS  PubMed  Google Scholar 

  • Ingelsson M, Jesneck J, Irizarry MC, Hyman BT, Rebeck GW. 2004. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease. Neurosci Lett 367: 228–231.

    CAS  PubMed  Google Scholar 

  • Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. 2000. Statins and the risk of dementia. Lancet 356: 1627–1631.

    CAS  PubMed  Google Scholar 

  • Johnson-Anuna LN, Eckert GP, Keller JH, Igbavboa U, Franke C, et al. 2005. Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther 312: 786–793.

    CAS  PubMed  Google Scholar 

  • Jordán J, Galindo MF, Miller RJ, Reardon CA, Getz GS, et al. 1998. Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci 18: 195–204.

    PubMed  Google Scholar 

  • Kabara JJ. 1973. A critical review of brain cholesterol metabolism. Prog Brain Res 40: 363–382.

    CAS  PubMed  Google Scholar 

  • Kirsch C, Eckert GP, Müller WE. 2003. Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol 65: 843–856.

    CAS  PubMed  Google Scholar 

  • Koch S, Donarski N, Goetze K, Kreckel M, Stuerenburg H-J, et al. 2001. Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res 42: 1143–1151.

    CAS  PubMed  Google Scholar 

  • La Du MJ, Shah JA, Reardon CA, Getz GS, Bu G, et al. 2000. Apolipoprotein E receptors mediate the effects of β-amyloid on astrocyte cultures. J Biol Chem 275: 33974–33980.

    CAS  Google Scholar 

  • La Du MJ, Shah JA, Reardon CA, Getz GS, Bu G, et al. 2001. Apolipoprotein E and apolipoprotein E receptors modulate Aβ-induced glial neuroinflammatory responses. Neurochem Int 39: 427–434.

    CAS  Google Scholar 

  • Lai EC. 2003. Lipid rafts make for slippery platforms. J Cell Biol 162: 365–370.

    CAS  PubMed  Google Scholar 

  • Lee S-J, Liyanage U, Bickel PE, Xia W, Lansbury PT, et al. 1998. A detergent-insoluble membrane compartment contains amyloid-β in vivo. Nat Med 4: 730–734.

    CAS  PubMed  Google Scholar 

  • Lichtenberg D, Goñi FM, Heerklotz H. 2005. Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem Sci 30: 430–436.

    CAS  PubMed  Google Scholar 

  • Lisanti MP, Scherer PE, Tang Z, Sargiacomo M. 1994. Caveolae, caveolin, and caveolin-rich membrane domains: A signaling hypothesis. Trends Cell Biol 4: 231–235.

    CAS  PubMed  Google Scholar 

  • Liu Y, Peterson DA, Schubert D. 1998. Amyloid-β peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc Natl Acad Sci USA 95: 13266–13271.

    CAS  PubMed  Google Scholar 

  • Lund EG, Guileyardo JM, Russell DW. 1999. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA 96: 7238–7243.

    CAS  PubMed  Google Scholar 

  • Lutjohann D, Breuer O, Ahlborg G, Nennesmo I, Siden A, et al. 1996. Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA 93: 9799–9804.

    CAS  PubMed  Google Scholar 

  • Lütjohann D, Stroick M, Bertsch T, Kühl S, Lindenthal B, et al. 2004. High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids 69: 431–438.

    PubMed  Google Scholar 

  • Ma J, Brewer H, Potter H. 1996. Alzheimer Aβ neurotoxicity: Promotion by anti-chymotrypsin, apoE4; inhibition by Aβ-related peptides. Neurobiol Aging 17: 773–780.

    CAS  PubMed  Google Scholar 

  • Mahley RW. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240: 622–630.

    CAS  PubMed  Google Scholar 

  • Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. 1984. Plasma lipoproteins: Apolipoprotein structure and function. J Lipid Res 25: 1277–1294.

    CAS  PubMed  Google Scholar 

  • Maltese WA. 1984. Cholesterol synthesis in cultured skin fibroblasts from patients with Huntington's disease. Biochem Med 32: 144–150.

    CAS  PubMed  Google Scholar 

  • Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, et al. 1995. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol 136: 107–122.

    CAS  PubMed  Google Scholar 

  • Masliah E, Mallory M, Veinbergs I, Miller A, Samuel W. 1996. Alternations in apolipoprotein E expression during aging and neurodegeneration. Prog Neurobiol 50: 493–503.

    CAS  PubMed  Google Scholar 

  • Mauch DH, Nägler K, Schumacher S, Göritz C, Müller E-C, et al. 2001. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294: 1354–1357.

    CAS  PubMed  Google Scholar 

  • Mcfarlane SI, Muniyappa R, Francisco R, Sowers JR. 2002. Pleiotropic effects of statins: Lipid reduction and beyond. J Clin Endocrinol Metab 87: 1451–1458.

    CAS  PubMed  Google Scholar 

  • Michikawa M. 2003. The role of cholesterol in pathogenesis of Alzheimer's disease: Dual metabolic interaction between amyloid β-protein and cholesterol. Mol Neurobiol 27: 1–12.

    CAS  PubMed  Google Scholar 

  • Mielke MM, Zandi PP, Sjögren M, Gustafson D, Östling S, et al. 2005. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 64: 1689–1695.

    CAS  PubMed  Google Scholar 

  • Mitter D, Reisinger C, Hinz B, Hollmann S, Yelamanchili SV, et al. 2003. The synaptophysin/synaptobrevin interaction critically depends on the cholesterol content. J Neurochem 84: 35–42.

    CAS  PubMed  Google Scholar 

  • Miyata M, Smith JD. 1996. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat Genet 14: 55–61.

    CAS  PubMed  Google Scholar 

  • Moore SA, Yoder E, Murphy S, Dutton GR, Spector AA. 1991. Astrocytes not neurons produce docosahexaenoic acid 22:6-ω-3 and arachidonic acid 20:4-ω6. J Neurochem 56: 518–524.

    CAS  PubMed  Google Scholar 

  • Morishima-Kawashima M, Ihara Y. 1998. The presence of amyloid β-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. Biochemistry 37: 15247–15253.

    CAS  PubMed  Google Scholar 

  • Naslavsky N, Stein R, Yanai A, Friedlander G, Taraboulos A. 1997. Characterization of detergent-insoluble complexes containing the cellular prion protein and scrapie isoform. J Biol Chem 272: 6324–6331.

    CAS  PubMed  Google Scholar 

  • Nathan BP, Jiang Y, Wong GK, Shen F, Brewer GJ, et al. 2002. Apolipoprotein E4 inhibits and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res 928: 96–105.

    CAS  PubMed  Google Scholar 

  • Ng Ying Kin NM, Palo J, Haltia M, Wolfe LS. 1983. High levels of brain dolichols in neuronal ceroid-lipofuscinosis and senescence. J Neurochem 40: 1465–1473.

    CAS  PubMed  Google Scholar 

  • Nishiyama K, Trapp BD, Ikezu T, Ransohoff RM, Tomita T, et al. 1999. Caveolin-3 upregulation activates β-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease. J Neurosci 19: 6538–6548.

    CAS  PubMed  Google Scholar 

  • North P, Fleischer S. 1983. Alteration of synaptic membrane cholesterol/phospholipid ratio using a lipid transfer protein. J Biol Chem 258(2): 1242–1253.

    CAS  PubMed  Google Scholar 

  • Norton WT, Igbal K, Tiffany C, Tellez-Nagel I. 1978. Huntington disease: Normal lipid composition of purified neuronal perikarya and whole cortex. Neurology 28: 812–816.

    CAS  PubMed  Google Scholar 

  • Oda T, Pasinetti GM, Osterburg HH, Anderson C, Johnson SAFCE. 1994. Purification and characterization of brain clusterin. Biochem Biophys Res Commun 204: 1131–1136.

    CAS  PubMed  Google Scholar 

  • Ohyama Y, Meaney S, Heverin M, Ekström L, Brafman A, et al. 2006. Studies on the transcriptional regulation of cholesterol24-hydroxylase (9CYP46A1): Marked insensitivity towards different regulatory axes. J Biol Chem 281: 3810-3820.

    CAS  PubMed  Google Scholar 

  • Op den Kamp JAF. 1979. Lipid asymmetry in membranes. Annu Rev Biochem 48: 47–71.

    CAS  PubMed  Google Scholar 

  • Palade GE. 1953. Fine structure of blood capillaries. J Appl Phys 24: 1424–1436.

    Google Scholar 

  • Papassotiropoulos A, Wollmer MA, Tsolaki M, Brunner F, Molyva D, et al. 2005. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry 66: 940–947.

    CAS  PubMed  Google Scholar 

  • Pappolla MA, Bryant-Thomas T, Herbert D, Pacheco J, Fabra Garcia M, et al. 2003. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61: 199–205.

    CAS  PubMed  Google Scholar 

  • Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. 1987a. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 917: 148–161.

    CAS  Google Scholar 

  • Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. 1987b. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain. J Biol Chem 262: 14352–14360.

    CAS  Google Scholar 

  • Poirier J. 1994. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 17: 525–530.

    CAS  PubMed  Google Scholar 

  • Poirier J. 2005. Apolipoprotein E, cholesterol transport, and synthesis in sporadic Alzheimer's disease. J Mol Neurosci 26: 355–361.

    CAS  Google Scholar 

  • Poirier J, Baccichet A, Dea D, Gauthier S. 1993a. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55: 81–90.

    CAS  Google Scholar 

  • Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, et al. 1993b. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697–699.

    CAS  Google Scholar 

  • Porn MI, Tenhunen J, Slotte JP. 1991. Increased steroid hormone secretion in mouse Leydig tumor cells after induction of cholesterol translocation by sphingomyelin degradation. Biochim Biophys Acta 1093: 7–12.

    CAS  PubMed  Google Scholar 

  • Porter FD. 2002. Malformation syndromes due to inborn errors of cholesterol synthesis. J Clin Invest 110: 715–724.

    CAS  PubMed  Google Scholar 

  • Puglielli L, Tanzi RE, Kovacs DM. 2003. Alzheimer's disease: The cholesterol connection. Nat Neurosci 6: 345–351.

    CAS  PubMed  Google Scholar 

  • Pullarkat RK, Reha H. 1982. Accumulation of dolichols in brains of elderly. J Biol Chem 257: 5991–5993.

    CAS  PubMed  Google Scholar 

  • Puttfarcken PS, Manelli AM, Falduto MT, Getz GS, La Du MJ. 1997. Effect of apolipoprotein E on neurite outgrowth and β-amyloid-induced toxicity in developing rat primary hippocampal cultures. J Neurochem 68: 760–769.

    CAS  PubMed  Google Scholar 

  • Quarles RH, Morell P, McFarlin DE. 1989. Diseases involving myelin. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Siegel G, Agranoff B, Albers RW, Molinoff P, editors. New York: Raven Press; pp. 697–713.

    Google Scholar 

  • Quest AFG, Leyton L, Párraga M. 2004. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol 82: 129–144.

    CAS  PubMed  Google Scholar 

  • Rall SC Jr, Weisgraber KH, Mahley RW. 1982. Human apolipoprotein E: The complete amino acid sequence. J Biol Chem 257: 4171–4178.

    CAS  PubMed  Google Scholar 

  • Ramsey RB, Nicholas HJ. 1972. Brain lipids. Adv Lipid Res 10: 143–232.

    CAS  PubMed  Google Scholar 

  • Rao AM, Igbavboa U, Semotuk M, Schroeder F, Wood WG. 1993. Kinetics and size of cholesterol lateral domains in synaptosomal membranes: Modification by sphingomyelinase and effects on membrane enzyme activity. Neurochem Int 23: 45–52.

    CAS  PubMed  Google Scholar 

  • Rebeck GW. 2004. Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis. J Mol Neurosci 23: 219–224.

    CAS  PubMed  Google Scholar 

  • Refolo LM, Pappolla MA, Malester B, LaFrancois J, Bryant- Thomas T, et al. 2000. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7: 321–331.

    CAS  PubMed  Google Scholar 

  • Rip JW, Rupar CA, Ravi K, Carroll KK. 1985. Distribution, metabolism, and function of dolichol and polyprenols. Prog Lipid Res 24: 269–309.

    CAS  PubMed  Google Scholar 

  • Roelofsen B. 1982. Phospholipases as tools to study the localization of phospholipids in biological membranes. A critical review. J Toxicol 1(1): 87–197.

    CAS  Google Scholar 

  • Roheim PS, Carey M, Forte T, Vega GL. 1979. Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci USA 76: 4646–4649.

    CAS  PubMed  Google Scholar 

  • Runz H, Rietdorf J, Tomic I, de Bernard M, Beyreuther K, et al. 2002. Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J Neurosci 22: 1679–1689.

    CAS  PubMed  Google Scholar 

  • Saunders AM, Strittmatter WJ, Schmechel D, St. George- Hyslop PH, Pericak-Vance MA, et al. 1993. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467–1472.

    CAS  PubMed  Google Scholar 

  • Schachter D, Abbott RE, Cogan U, Flamm M. 1983. Lipid fluidity of the individual hemileaflets of human erythrocyte membranes. Ann NY Acad Sci 414: 19–28.

    CAS  PubMed  Google Scholar 

  • Schinkel AH. 1997. The physiological function of drug-transporting P-glycoproteins. Semin Cancer Biol 8: 161–170.

    CAS  PubMed  Google Scholar 

  • Schroeder F, Frolov AA, Murphy EJ, Atshaves BP, Pu L, et al. 1996. Recent advances in membrane cholesterol domain dynamics and intracellular cholesterol trafficking. Proc Soc Exp Biol Med 213: 150–177.

    CAS  PubMed  Google Scholar 

  • Schroeder F, Morrison WJ, Gorka C, Wood WG. 1988. Transbilayer effects of ethanol on fluidity of brain membrane leaflets. Biochim Biophys Acta 946: 85–94.

    CAS  PubMed  Google Scholar 

  • Schroeder F, Nemecz G, Wood WG, Morrot G, Ayraut-Jarrier M, et al. 1991. Transmembrane distribution of sterol in the human erythrocyte. Biochim Biophys Acta 1066: 183–192.

    CAS  PubMed  Google Scholar 

  • Shepherd J, Blauw GJ, Murphy MB, Bollen ELEM, Buckley BM, et al. 2002. Pravastatin in elderly at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 360: 1623–1630.

    CAS  PubMed  Google Scholar 

  • Simons K, Ikonen E. 2000. How cells handle cholesterol. Science 290: 1721–1726.

    CAS  PubMed  Google Scholar 

  • Simons M, Keller P, Destrooper B, Beyreuther K, Dotti CG, et al. 1998. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95: 6460–6464.

    CAS  PubMed  Google Scholar 

  • Sipione S, Rigamonti D, Valenza M, Zuccato C, Conti L, et al. 2002. Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum Mol Genet 15: 1953–1965.

    Google Scholar 

  • Slotte JP, Bierman EL. 1988. Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem J 250: 653–658.

    CAS  PubMed  Google Scholar 

  • Sparks DL, Connor DJ, Browne PJ, Lopez JE, Sabbagh MN. 2002. HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advised to use one that crosses the blood–brain barrier. J Nutr Health Aging 6: 324–331.

    CAS  PubMed  Google Scholar 

  • Srere PA, Chaikoff IL, Treitman SS, Burstein LS. 1950. The extrahepatic synthesis of cholesterol. J Biol Chem 182: 629–634.

    CAS  Google Scholar 

  • Subczynski WK, Kusumi A. 2003. Dynamics of raft molecules in the cell and artificial membranes: Approaches by pulse EPR spin labeling and single molecule optical microscopy. Biochim Biophys Acta 1610: 231–243.

    CAS  PubMed  Google Scholar 

  • Sun Y, Wu S, Bu G, Onifade MK, Patel SN, et al. 1998. Glial fibrillary acidic protein–apolipoprotein E (apoE) transgenic mice: Astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci 18: 3261–3272.

    CAS  PubMed  Google Scholar 

  • Suresh S, Yan Z, Patel RC, Patel YC, Patel SC. 1998. Cellular cholesterol storage in the Niemann–Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D. J Neurochem 70: 242–251.

    CAS  PubMed  Google Scholar 

  • Teixeira A, Chaverot N, Schröder C, Strosberg AD, Couraud P-O, et al. 1999. Requirement of caveolae microdomains in extracellular signal-regulated kinase and focal adhesion kinase activation induced by endothelin-1 in primary astrocytes. J Neurochem 72: 120–128.

    CAS  PubMed  Google Scholar 

  • Teter B, Finch CE. 2004. Caiban's heritance and the genetics of neuronal aging. Trends Neurosci 27: 627–632.

    CAS  PubMed  Google Scholar 

  • Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, et al. 2002. Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J Neurosci Res 68: 331–336.

    CAS  PubMed  Google Scholar 

  • Thiele C, Hannah MJ, Fahrenholz F, Huttner WB. 2000. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol 2: 42–49.

    CAS  PubMed  Google Scholar 

  • Titov VN. 1997. Structure of Apo A-I high density lipoproteins: A review. Biochemistry (Moscow) 62: 3–19.

    Google Scholar 

  • Tong H, Holstein SA, Hohl RJ. 2005. Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells. Anal Biochem 336: 51–59.

    CAS  PubMed  Google Scholar 

  • Tosi MR, Bottura G, Lucchi P, Reggiani A, Trinchero A, et al. 2003. Cholesteryl esters in human malignant neoplasms. Int J Mol Med 11: 95–98.

    CAS  PubMed  Google Scholar 

  • Turley SD, Dietschy JM. 1997. Regional variation in cholesterol synthesis and low-density lipoprotein transport in the brain of the fetus, newborn, and adult animal. Nutr Metab Cardiovasc Dis 7: 195–201.

    CAS  Google Scholar 

  • Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, et al. 2005. Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J Neurosci 25: 9932–9939.

    CAS  PubMed  Google Scholar 

  • Vance DE, Van den Bosch H. 2001. Cholesterol in the year 2000. Biochim Biophys Acta 1529: 1–8.

    Google Scholar 

  • Vance JE, Hayashi H, Karten B. 2005. Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol 16: 193–212.

    CAS  PubMed  Google Scholar 

  • Vanier MT, Rousson R, Louisot P. 1983. Chromatofocusing of skin fibroblast sphingomyelinase: Alterations in Niemann–Pick disease type C shared by GM1-gangliosidosis. Clin Chim Acta 130: 155–161.

    CAS  PubMed  Google Scholar 

  • Waelsch H, Sperry WM, Stoyanoff VA. 1940. Lipid metabolism in brain during myelination. J Biol Chem 135: 297–302.

    CAS  Google Scholar 

  • Wassmann S, Laufs U, Bäumer AT, Müller K, Konkol C, et al. 2001. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth cells: Involvement of angiotensin AT1 receptor expression Rac1 GTPase. Mol Pharmacol 59: 646–654.

    CAS  PubMed  Google Scholar 

  • Weisgraber KH, Rall SC, Mahley RW. 1981. Human E apoprotein heterogeneity cysteine–arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 256: 9077–9083.

    CAS  PubMed  Google Scholar 

  • White F, Nicoll JA, Roses AD, Horsburgh K. 2001. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol Dis 8: 611–625.

    CAS  PubMed  Google Scholar 

  • Wolfe LS, Ng Ying Kin NM, Palo J, Bergeron C, Kotila M, et al. 1985. Dolichols are elevated in brain tissue from Alzheimer's disease, but not in urinary sediment from Alzheimer's disease and Down's syndrome. Neurochem Pathol 3: 213–221.

    CAS  PubMed  Google Scholar 

  • Wolozin B. 2004. Cholesterol, statins, and dementia. Curr Opin Lipidol 15: 667–672.

    CAS  PubMed  Google Scholar 

  • Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. 2000. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57: 1439–1443.

    CAS  PubMed  Google Scholar 

  • Wood WG, Schroeder F. 1988. Membrane structure in aged humans and animals. Central Nervous System Disorders of Aging: Clinical Intervention and Research. Strong R, Wood WG, Burke WJ, editors. New York: Raven Press; pp. 199–209.

    Google Scholar 

  • Wood WG, Eckert GP, Igbavboa U, Müller WE. 2003. Amyloid β-peptide interactions with membranes and cholesterol: Causes or casualties of Alzheimer's disease. Biochim Biophys Acta 1610: 281–290.

    Google Scholar 

  • Wood WG, Gorka C, Schroeder F. 1989a. Acute and chronic effects of ethanol on transbilayer membrane domains. J Neurochem 52: 1925–1930.

    CAS  Google Scholar 

  • Wood WG, Sun GY, Schroeder F. 1989b. Membrane properties of dolichol in different age groups of mice. Chem Phys Lipids 51: 219–226.

    CAS  Google Scholar 

  • Wood WG, Gorka C, Williamson LS, Strong R, Sun AY, et al. 1986. Dolichol alters dynamic and static properties of mouse synaptosomal plasma membranes. FEBS Lett 205(1): 25–28.

    CAS  PubMed  Google Scholar 

  • Wood WG, Igbavboa U, Eckert GP, Johnson-Anuna LN, Müller WE. 2005. Is hypercholesterolemia a risk factor for Alzheimer's disease? Mol Neurobiol 31: 185–192.

    CAS  PubMed  Google Scholar 

  • Wood WG, Igbavboa U, Rao AM, Schroeder F, Avdulov NA. 1995. Cholesterol oxidation reduces Ca2+/Mg2+-ATPase activity, interdigitation, and increases fluidity of brain synaptic plasma membranes. Brain Res 683: 36–42.

    CAS  PubMed  Google Scholar 

  • Wood WG, Rao AM, Igbavboa U, Semotuk M. 1993. Cholesterol exchange and lateral cholesterol pools in synaptosomal membranes of pair-fed control and chronic ethanol-treated mice. Alcohol Clin Exp Res 17: 345–350.

    CAS  PubMed  Google Scholar 

  • Wood WG, Schroeder F, Avdulov NA, Chochina SV, Igbavboa U. 1999. Recent advances in brain cholesterol dynamics: Transport, domains and Alzheimer's disease. Lipids 34: 225–234.

    CAS  PubMed  Google Scholar 

  • Wood WG, Schroeder F, Hogy L, Rao AM, Nemecz G. 1990. Asymmetric distribution of a fluorescent sterol in synaptic plasma membranes: Effects of chronic ethanol consumption. Biochim Biophys Acta 1025: 243–246.

    CAS  PubMed  Google Scholar 

  • Wood WG, Schroeder F, Igbavboa U, Avdulov NA, Chochina SV. 2002. Brain membrane cholesterol domains, aging, and amyloid β-peptides. Neurobiol Aging 23: 685–694.

    CAS  PubMed  Google Scholar 

  • Wu C, Butz S, Ying Ys, Anderson RGW. 1997. Tyrosine kinase receptors concentrated in caveolae-like domains from neuronal plasma membrane. J Biol Chem 272: 3554–3559.

    CAS  PubMed  Google Scholar 

  • Xu Q, Li YH, Cyras C, Sanan DA, Cordell B. 2000. Isolation and characterization of apolipoproteins from murine microglia. J Biol Chem 275: 31770–31777.

    CAS  PubMed  Google Scholar 

  • Yamada E. 1955. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1: 445–458.

    CAS  PubMed  Google Scholar 

  • Ye S, Huang Y, Mullendorff K, Dong L, Giedt G, et al. 2005. Apolipoprotein (apo) E4 enhances amyloid-β peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target. Proc Natl Acad Sci USA 102: 18700-18705.

    CAS  PubMed  Google Scholar 

  • Zachowski A. 1993. Phospholipids in animal eukaryotic membranes: Transverse asymmetry and movement. Biophys J 294: 1–14.

    CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the National Institutes of Health AG-23524, AG-18357, NATO Collaborative Linkage Grant (980136), and resources/facilities of the Minneapolis VA Medical Center.

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC.

About this entry

Cite this entry

Wood, W.G., Igbavboa, U., Eckert, G.P., Müller, W.E. (2007). Cholesterol—A Janus-Faced Molecule in the Central Nervous System. In: Lajtha, A., Reith, M.E.A. (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-30380-2_7

Download citation

Publish with us

Policies and ethics